Clinical Pharmacokinetics of Mycophenolate Mofetil, Clinical Pharmacokinetics, vol.34, issue.6, pp.429-55, 1998. ,
DOI : 10.2165/00003088-199834060-00002
Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.368, issue.5, pp.415-435, 2003. ,
DOI : 10.1007/s00210-003-0814-4
Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2, American Journal of Transplantation, vol.41, issue.1, pp.987-94, 2005. ,
DOI : 10.1046/j.1523-1755.2001.00782.x
Drug Interaction Between Mycophenolate Mofetil and Tacrolimus Detectable Within Therapeutic Mycophenolic Acid Monitoring in Renal Transplant Patients, Therapeutic Drug Monitoring, vol.21, issue.5, pp.536-545, 1999. ,
DOI : 10.1097/00007691-199910000-00008
inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats, J Pharmacol Exp Ther, vol.309, pp.1029-1064 ,
Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus, American Journal of Transplantation, vol.13, issue.9, pp.2236-2279, 2005. ,
DOI : 10.1016/S1053-2498(01)00251-0
Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus, Xenobiotica, vol.26, issue.3, 2012. ,
DOI : 10.1124/dmd.105.006122
Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters, Xenobiotica, vol.45, issue.9, pp.752-759, 2011. ,
DOI : 10.1200/JCO.2009.24.2669
URL : https://hal.archives-ouvertes.fr/inserm-00926385
The Role of Organic Anion???Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics, Clinical Pharmacology & Therapeutics, vol.87, issue.1, pp.100-108, 2010. ,
DOI : 10.1086/379378
URL : https://hal.archives-ouvertes.fr/inserm-00415314
Mycophenolic Acid Plasma Concentrations: Influence of Comedication, Therapeutic Drug Monitoring, vol.23, issue.1, pp.35-43, 2001. ,
DOI : 10.1097/00007691-200102000-00007
Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma, J Am Soc Nephrol, vol.10, pp.1159-69, 1999. ,
Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A, Journal of Pharmacology and Experimental Therapeutics, vol.304, issue.2, pp.610-616, 2003. ,
DOI : 10.1124/jpet.102.041921
Long-lasting Inhibitory Effects of Cyclosporin A, but Not Tacrolimus, on OATP1B1- and OATP1B3-mediated Uptake, Drug Metabolism and Pharmacokinetics, vol.27, issue.4, 2012. ,
DOI : 10.2133/dmpk.DMPK-11-RG-096
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study, Nephrology Dialysis Transplantation, vol.14, issue.3, pp.706-714, 1999. ,
DOI : 10.1093/ndt/14.3.706
Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil, Drug Metabolism and Disposition, vol.35, issue.8, pp.1400-1407, 2007. ,
DOI : 10.1124/dmd.106.013615
Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3, Biochemical Pharmacology, vol.74, issue.1, pp.161-169, 2007. ,
DOI : 10.1016/j.bcp.2007.03.024
Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid, Therapeutic Drug Monitoring, vol.23, issue.2, pp.119-147, 2001. ,
DOI : 10.1097/00007691-200104000-00005
ROLE OF MRP2 IN THE HEPATIC DISPOSITION OF MYCOPHENOLIC ACID AND ITS GLUCURONIDE METABOLITES: EFFECT OF CYCLOSPORINE, Drug Metabolism and Disposition, vol.34, issue.2, pp.261-267, 2006. ,
DOI : 10.1124/dmd.105.006122
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings, Transplant Immunology, vol.5, issue.3, pp.225-257, 1997. ,
DOI : 10.1016/S0966-3274(97)80042-1
Figure 1: proposed pathways for MPA hepatic disposition and enterohepatic cycling, and mechanism for its interaction with cyclosporine. The figure is based on evidence provided by the literature, 1998. ,